FDA 483 - Drew J. Winston, MD - February 22, 2021

An FDA inspection of Drew J. Winston, M.D., Clinical Investigator in Los Angeles, CA, from February 4-22, 2021, revealed a significant failure to report adverse effects to the sponsor. The investigator did not record numerous adverse events from subject source documents into the electronic case report forms (eCRFs) for two investigational drug studies.